Skip to main content
. 2020 Apr 9;4(7):1432–1439. doi: 10.1182/bloodadvances.2019001304

Figure 1.

Figure 1.

Regrade of JULIET trial patient-level data showed 64 patients as having any-grade CRS by Penn scale, 63 patients by Lee scale, and 61 patients by ASTCT criteria. (A) Frequency of CRS event grades by the Penn, Lee, and ASTCT grading scales (N = 111). The numbers inside of the columns refer to absolute number of patients. (B) Cross-classification of CRS according to the 3 grading scales: Penn, Lee, and ASTCT.